GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1426 - 1450 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G28868ZC
250
IgG Patient 2 3 mild
G28868ZC
25
IgM Patient 2 3 mild
G28868ZC
38
IgA Patient 3 -180 mild
G28868ZC
232
IgA Patient 3 11 mild
G28868ZC
374
IgG Patient 3 -180 mild
G28868ZC
39
IgM Patient 3 -180 mild
G28868ZC
68
IgA Patient 3 4 mild
G28868ZC
395
IgG Patient 3 11 mild
G28868ZC
46
IgG Patient 3 4 mild
G28868ZC
44
IgM Patient 3 11 mild
G28868ZC
122
IgM Patient 3 4 mild
G28868ZC
128
IgA Patient 4 12 mild
G28868ZC
348
IgG Patient 4 12 mild
G28868ZC
98
IgM Patient 4 12 mild
G28868ZC
153
IgA Patient 1 10 moderate
G29011JC
385
IgA Patient 1 22 moderate
G29011JC
405
IgA Patient 1 6 moderate
G29011JC
387
IgG Patient 1 10 moderate
G29011JC
26
IgG Patient 1 22 moderate
G29011JC
39
IgG Patient 1 6 moderate
G29011JC
27
IgM Patient 1 10 moderate
G29011JC
46
IgM Patient 1 22 moderate
G29011JC
172
IgM Patient 1 6 moderate
G29011JC
40
IgA Patient 2 15 mild
G29011JC
504

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024